scholarly journals The ameliorative effect of protein hydrolysate on the imazamox-damaged young wheat plants

2021 ◽  
Vol 13 (31) ◽  
pp. 68-76
Author(s):  
Dobrinka Balabanova ◽  
Keyword(s):  
Protein Hydrolysate ◽  
Wide Spectrum ◽  
Abiotic Stress Tolerance ◽  
Combined Treatment ◽  
Additional Treatment ◽  
Antioxidative Defense ◽  
Application Rates ◽  
Wide Range ◽  
Ameliorative Effect ◽  
Mammalian Toxicity

The plant biostimulants (PBs) are a wide range of microbial and/or organic compounds applied to crops to improve the physiological processes such as nutrition efficiency, plant development and abiotic stress tolerance. Imazamox is a herbicide characterised with a wide spectrum of weed control, low application rates and low mammalian toxicity, but also with a high soil persistence. Therefore, the residual amounts of imazamox may negatively affect subsequent sensitive crops in the crop rotation. In the current study we investigated the effect of a single and combined treatment with imazamox and a plant biostimulant (protein hydrolisate) on the antioxidative defense system and the detoxification metabolism of wheat young plants. The result showed that the seed imbibition with 10 μM imazamox inhibits the growth of the young wheat plants. A slight improvement was found due to the additional treatment with protein hydrolysate of the wheat plants damaged by imazamox herbicide. According to the results, this improving effect on the growth does not ameliorate the plant detoxification metabolism such as glutathione S-transferases or antioxidative defense. However, the improving effect is low and insufficient to restore the plant growth and functioning and its effects on wheat production are not studied yet.

scholarly journals Prospects for Abiotic Stress Tolerance in Crops Utilizing Phyto- and Bio-Stimulants

2021 ◽  
Vol 5 ◽  
Author(s):  
Nidhi Rai ◽  
Shashi Pandey Rai ◽  
Birinchi Kumar Sarma
Keyword(s):  
Plant Growth ◽  
Environmental Conditions ◽  
Mycorrhizal Fungi ◽  
Protein Hydrolysate ◽  
Abiotic Stress Tolerance ◽  
Nutrient Use Efficiency ◽  
Crop Plants ◽  
Wide Range ◽  
Use Efficiency ◽  
Adverse Environmental Conditions

Environmental stressors such as salinity, drought, high temperature, high rainfall, etc. have already demonstrated the negative impacts on plant growth and development and thereby limiting productivity of the crops. Therefore, in the time to come, more sustainable efforts are required in agricultural practices to ensure food production and security under such adverse environmental conditions. A most promising and eco-friendly way to achieve this goal would be to apply biostimulants to address the environmental concerns. Non-microbial biostimulants such as humic substances (HA), protein hydrolysate, plant-based products and seaweed extracts (SWE), etc. and/or microbial inoculants comprising of plant growth-promoting microbes such as arbuscular mycorrhizal fungi (AMF), fluorescent and non-fluorescent Pseudomonas, Trichoderma spp., Bacillus spp. etc. have tremendous potentiality to enhance plant growth, flowering, crop productivity, nutrient use efficiency (NUE) and translocation, as well as enhancing tolerance to a wide range of abiotic stresses by modifying physiological, biological and biochemical processes of the crop-plants. Similarly, application techniques and timing are also important to achieve the desired results. In this article we discussed the prospects of using seaweed, microbial, and plant-based biostimulants either individually or in combination for managing environmental stresses to achieve food security in a sustainable way. Particular attention was given to the modifications that take place in plant's physiology under adverse environmental conditions and how different biostimulants re-program the host's physiology to withstand such stresses. Additionally, we also discussed how application of biostimulants can overcome the issue of nutrient deficiency in agricultural lands and improve their use efficiency by crop plants.

Cucurbitacins as Anticancer Agents: A Patent Review

2019 ◽  
Vol 14 (2) ◽  
pp. 133-143 ◽  
Author(s):  
Hidayat Hussain ◽  
Ivan R. Green ◽  
Muhammad Saleem ◽  
Khanzadi F. Khattak ◽  
Muhammad Irshad ◽  
...  
Keyword(s):  
Anticancer Agents ◽  
Wide Spectrum ◽  
Biological Effects ◽  
Therapeutic Effects ◽  
Cytotoxic Effects ◽  
Natural Sources ◽  
Oh Groups ◽  
Drug Candidates ◽  
The Past ◽  
Wide Range

Background: Cucurbitacins belong to a group of tetracyclic triterpenoids that display a wide range of biological effects. In the past, numerous cucurbitacins have been isolated from natural sources and many active compounds have been synthesized using the privileged scaffold in order to enhance its cytotoxic effects. Objective: his review covers patents on the therapeutic effects of natural cucurbitacins and their synthetic analogs published during the past decade. By far, the majority of patents published are related to cancer and Structure-Activity Relationships (SAR) of these compounds are included to lend gravitas to this important class of natural products. Methods: The date about the published patents was downloaded via online open access patent databases. Results: Cucurbitacins display significant cytotoxic properties, in particular cucurbitacins B and D which possess very potent effects towards a number of cancer cells. Numerous cucurbitacins isolated from natural sources have been derivatized through chemical modification at the C(2)-OH and C(25)- OH groups. Most importantly, an acyl ester of the C(25)-OH and, iso-propyl, n-propyl and ethyl ether groups of the C(2)-OH demonstrated the most increased cytotoxic activity. Conclusion: The significant cytotoxic effects of natural and semi-synthetic cucurbitacins make them attractive as new drug candidates. Moreover, cucurbitacins have the capability to form conjugates with other anticancer drugs which will synergistically enhance their anticancer effects. The authors believe that in order to get lead compounds, there should be a greater focus on the synthesis of homodimers, heterodimers, and halo derivatives of cucurbitacins. In the opinion of the authors the analysis of the published patents on the cucurbitacins indicates that these compounds can be developed into a regimen to treat a wide spectrum of cancers.

scholarly journals Greater trochanteric pain syndrome: Evaluation and management of a wide spectrum of pathology

2021 ◽  
Vol 9 ◽  
pp. 205031212110225
Author(s):  
Mark A Pianka ◽  
Joseph Serino ◽  
Steven F DeFroda ◽  
Blake M Bodendorfer
Keyword(s):  
Wide Spectrum ◽  
Pain Syndrome ◽  
Operative Management ◽  
Hip Pain ◽  
Greater Trochanteric Pain Syndrome ◽  
Trochanteric Bursitis ◽  
Treatment Indications ◽  
Careful Clinical Examination ◽  
Wide Range ◽  
Tendon Pathology

Greater trochanteric pain syndrome is a common cause of lateral hip pain, encompassing a spectrum of disorders, including trochanteric bursitis, abductor tendon pathology, and external coxa saltans. Greater trochanteric pain syndrome is primarily a clinical diagnosis, and careful clinical examination is essential for accurate diagnosis and treatment. A thorough history and physical exam may be used to help differentiate greater trochanteric pain syndrome from other common causes of hip pain, including osteoarthritis, femoroacetabular impingement, and lumbar stenosis. Although not required for diagnosis, plain radiographs and magnetic resonance imaging may be useful to exclude alternative pathologies or guide treatment of greater trochanteric pain syndrome. The majority of patients with greater trochanteric pain syndrome respond well to conservative management, including physical therapy, non-steroidal anti-inflammatory drugs, and corticosteroid injections. Operative management is typically indicated in patients with chronic symptoms refractory to conservative therapy. A wide range of surgical options, both open and endoscopic, are available and should be guided by the specific etiology of pain. The purpose of this review is to highlight pertinent clinical and radiographic features used in the diagnosis and management of greater trochanteric pain syndrome. In addition, treatment indications, techniques, and outcomes are described.

scholarly journals MXenes for future nanophotonic device applications

Nanophotonics ◽  
2020 ◽  
Vol 9 (7) ◽  
pp. 1831-1853
Author(s):  
Jaeho Jeon ◽  
Yajie Yang ◽  
Haeju Choi ◽  
Jin-Hong Park ◽  
Byoung Hun Lee ◽  
...  
Keyword(s):  
Solar Cells ◽  
Transition Metal ◽  
Wide Spectrum ◽  
Building Blocks ◽  
Optoelectronic Device ◽  
High Yield ◽  
Saturable Absorption ◽  
Nanophotonic Device ◽  
Wide Range ◽  
Device Applications

AbstractTwo-dimensional (2D) layers of transition metal carbides, nitrides, or carbonitrides, collectively referred to as MXenes, are considered as the new family of 2D materials for the development of functional building blocks for optoelectronic and photonic device applications. Their advantages are based on their unique and tunable electronic and optical properties, which depend on the modulation of transition metal elements or surface functional groups. In this paper, we have presented a comprehensive review of MXenes to suggest an insightful perspective on future nanophotonic and optoelectronic device applications based on advanced synthesis processes and theoretically predicted or experimentally verified material properties. Recently developed optoelectronic and photonic devices, such as photodetectors, solar cells, fiber lasers, and light-emitting diodes are summarized in this review. Wide-spectrum photodetection with high photoresponsivity, high-yield solar cells, and effective saturable absorption were achieved by exploiting different MXenes. Further, the great potential of MXenes as an electrode material is predicted with a controllable work function in a wide range (1.6–8 eV) and high conductivity (~104 S/cm), and their potential as active channel material by generating a tunable energy bandgap is likewise shown. MXene can provide new functional building blocks for future generation nanophotonic device applications.

Outcomes Following Surgical Treatment of Hamate Arthrosis Lunotriquetral Ligament Injuries

Hand ◽  
2021 ◽  
pp. 155894472110432
Author(s):  
Jesse Meaike ◽  
Joshua Meaike ◽  
Sanjeev Kakar
Keyword(s):  
Surgical Treatment ◽  
Treatment Group ◽  
Combined Treatment ◽  
Additional Treatment ◽  
Ligament Injuries ◽  
Interosseous Ligament ◽  
Institutional Review ◽  
Lunotriquetral Ligament ◽  
Treatment Plans ◽  
And Function

Background: An institutional review board–approved study of the functional outcomes of patients after surgical treatment of hamate arthrosis lunotriquetral ligament tear (HALT) lesions was conducted. Methods: In all, 21 wrists in 19 patients underwent arthroscopic, open, or combined treatment of HALT lesions. Seven patients underwent isolated hamate debridement and 14 had concomitant procedures to address lunotriquetral pathology. Nineteen wrists underwent procedures to address additional pathology, including triangular fibrocartilage complex, ulnotriquetral ligament split, and scapholunate ligament injuries. Results: Mayo wrist scores increased from 54 to 71. Sixteen patients had no or mild pain postoperatively, compared with none preoperatively. When stratified by lunotriquetral interosseous ligament management, 75% of the limited treatment group (none or debridement) and 78% of the additional treatment group reported improved pain. Three patients underwent additional surgeries for persistent pain. Conclusion: Resection of the proximal pole of the hamate can improve pain and function for patients with ulnar-sided wrist pain secondary to a HALT lesion. Concomitant wrist pathologies should be considered when determining treatment plans.

A Review on Meropenem

2021 ◽  
pp. 5034-5038
Author(s):  
Mohsina Abed ◽  
Sara Yousuf
Keyword(s):  
Intravenous Administration ◽  
Wide Spectrum ◽  
Gastrointestinal Haemorrhage ◽  
The Body ◽  
Antibacterial Drug ◽  
Bacterial Strains ◽  
Enhanced Absorption ◽  
Bacterial Cell Death ◽  
Wide Range ◽  
Synthetic Derivative

Meropenem is a new Carbapenem antibacterial agent with wide spectrum of activity for intravenous administration. It is synthetic derivative of Thienamycin. Three analogues of Meropenem are evaluated and active against 18 bacterial strains. Meropenem causes rapid bacterial cell death by covalently binding to penicillin binding proteins (PBS). Structural modification at C-2 position, produced double promoiety prodrug of Meropenem and increases bioavailability of oral administration. Other forms of drug such as liposome and nanoparticles are also available with enhanced absorption. 14C labelled Meropenem prepared from 14C Dimethylamine hydrochloride is used for the analysis of M. tuberculosis transpeptidase. ICI213,689 is the only metabolite of Meropenem and it is inactive. Meropenem penetrates well into the body fluids and tissues including cerebrospinal fluid. Its bioavailability is 100% on intravenous administration. Hence it is used in the treatment of meningitis, febrile neutropenia, anthrax and various other skin and skin structure infections. Dosage reduction is required in patient with reduced renal function but not in hepatic impairment. Seizures, gastrointestinal haemorrhage are observed in patients. Vabmoere is the combination of Meropenem and Vaborbactam which is active against the Carbapenem resistant Enterobacteriacea. Meropenem is an effective broad-spectrum antibacterial drug for the treatment of wide range of infection including polymicrobial infection in both children and adult.

A Comprehensive Assessment Tool for Patient Registry Software Systems: The CIPROS Checklist

2015 ◽  
Vol 54 (05) ◽  
pp. 447-454 ◽  
Author(s):  
U. Mansmann ◽  
D. Lindoerfer
Keyword(s):  
Systematic Review ◽  
Critical Appraisal ◽  
Assessment Tool ◽  
Wide Spectrum ◽  
Patient Registry ◽  
Software Systems ◽  
Software System ◽  
Review Of The Literature ◽  
Patient Registries ◽  
Wide Range

SummaryBackground: Patient registries are an important instrument in medical research. Often their structure is complex and their implementation uses composite software systems to meet the wide spectrum of challenges.Objectives: For the implementation of a registry, there is a wide range of commercial, open source, and self-developed systems available and a minimal standard for the critical appraisal of their architecture is needed.Methods: We performed a systematic review of the literature to define a catalogue of relevant criteria to construct a minimal appraisal standard.Results: The CIPROS list is developed based on 64 papers which were found by our systematic review. The list covers twelve sections and contains 72 items.Conclusions: The CIPROS list supports developers to assess requirements on existing systems and strengthens the reporting of patient registry software system descriptions. It can be a first step to create standards for patient registry software system assessments.

Plant Growth Response to the Phytotoxin Viridiol Produced by the FungusGliocladium virens

Weed Science ◽  
1988 ◽  
Vol 36 (5) ◽  
pp. 683-687 ◽  
Author(s):  
Richard W. Jones ◽  
W. Thomas Lanini ◽  
Joseph G. Hancock
Keyword(s):  
Root Zone ◽  
Wide Spectrum ◽  
Soil Surface ◽  
Application Rate ◽  
Herbicidal Activity ◽  
Peat Moss ◽  
Application Rates ◽  
Gliocladium Virens ◽  
Root Necrosis ◽  
Shoot Weight

Gliocladium virens, when grown on peat moss amended with sucrose and ammonium nitrate and then applied to soil, resulted in root necrosis. Herbicidal activity was correlated with fungal production of the phytotoxin viridiol. Viridiol had a wide spectrum of activity; it was particularly effective against annual composite species but was less effective in monocot control. Emergence of most weeds was reduced >90% at application rates of 8.7% (of total volume) or less. Treated seedling dry weights were drastically reduced. Applications of 4.5% reduced root and shoot weight of redroot pigweed by 93 and 98%, respectively. Crops were affected at higher treatment levels; however, the toxicity was readily avoided by applying the mycoherbicide out of the root zone of the crop, instead applying it between the seed and the soil surface. Viridiol production, which confers herbicidal activity, was detected 3 days after incorporation of the fungus-peat mixture. Viridiol production peaked on days 5 and 6 at approximately 25 μg viridiol/100 ml soil, based upon an application rate of 11%, then declined to undetectable levels by the end of 2 weeks.

Investigation on a Type of Flow Control to Weaken Unsteady Separated Flows by Unsteady Excitation in Axial Flow Compressors

2004 ◽  
Author(s):  
Xin-Qian Zheng ◽  
Xiao-Bo Zhou ◽  
Sheng Zhou
Keyword(s):  
Wide Spectrum ◽  
Excitation Frequency ◽  
Axial Flow ◽  
Maximum Velocity ◽  
Excitation Amplitude ◽  
High Order Scheme ◽  
Wide Range ◽  
Optimal Excitation ◽  
Suction And Blowing ◽  
Axial Flow Compressors

By solving unsteady Reynolds-averaged 2-D N-S equations discretized by a high-order scheme, the results showed that the disordered unsteady separated flow could be effectively controlled by periodic suction and blowing in a wide range of incidence, resulting in enhancement of time-averaged aerodynamic performances. The effects of unsteady excitation frequency, amplitude and excitation location were investigated in detail. The effective excitation frequency spans a wide spectrum and there is an optimal excitation frequency that is nearly equal to the Characteristic frequency of vortex shedding. Excitation amplitude exhibits a threshold value (nearly 10% in term of the ratio of maximum velocity of periodic suction and blowing to the velocity of free flow) and an optimal value (nearly 35%). The optimal excitation location is just upstream of the separation point. We also explored feasible unsteady actuators by utilizing upstream wake for constraining unsteady separation in axial flow compressors.

scholarly journals Embryonic Stage of Congenital Zika Virus Infection Determines Fetal and Postnatal Outcomes in Mice

Viruses ◽  
2021 ◽  
Vol 13 (9) ◽  
pp. 1807
Author(s):  
Eri Nakayama ◽  
Yasuhiro Kawai ◽  
Satoshi Taniguchi ◽  
Jessamine E. Hazlewood ◽  
Ken-ichi Shibasaki ◽  
...  
Keyword(s):  
Zika Virus ◽  
Neutralizing Antibodies ◽  
Neonatal Death ◽  
Motor Behavior ◽  
Wide Spectrum ◽  
Fetal Loss ◽  
Congenital Infection ◽  
Sensory Function ◽  
Zikv Infection ◽  
Wide Range

Zika virus (ZIKV) infection during pregnancy causes a wide spectrum of congenital abnormalities and postnatal developmental sequelae such as fetal loss, intrauterine growth restriction (IUGR), microcephaly, or motor and neurodevelopmental disorders. Here, we investigated whether a mouse pregnancy model recapitulated a wide range of symptoms after congenital ZIKV infection, and whether the embryonic age of congenital infection changed the fetal or postnatal outcomes. Infection with ZIKV strain PRVABC59 from embryonic day 6.5 (E6.5) to E8.5, corresponding to the mid-first trimester in humans, caused fetal death, fetal resorption, or severe IUGR, whereas infection from E9.5 to E14.5, corresponding to the late-first to second trimester in humans, caused stillbirth, neonatal death, microcephaly, and postnatal growth deficiency. Furthermore, 4-week-old offspring born to dams infected at E12.5 showed abnormalities in neuropsychiatric state, motor behavior, autonomic function, or reflex and sensory function. Thus, our model recapitulated the multiple symptoms seen in human cases, and the embryonic age of congenital infection was one of the determinant factors of offspring outcomes in mice. Furthermore, maternal neutralizing antibodies protected the offspring from neonatal death after congenital infection at E9.5, suggesting that neonatal death in our model could serve as criteria for screening of vaccine candidates.

Sign in / Sign up

Export Citation Format

Share Document